Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11567728 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Optimization of Treatment With Adalimumab (Humira)
Condition: Rheumatoid Arthritis (RA)
Interventions: Other: DAS28-IOMS;   Other: 0SJ-IOMS;   Other: Routine Care (RC)

Indicates status has not been verified in more than two years